The role of transforming growth factor β1 in the vascular system

Cardiovascular Pathology

Volumn 14, Issue 1, 2005, Pages 28-36

  Ghosh, Jonathan ^a,b   Murphy, Michael O ^a,b   Turner, Neill ^a   Khwaja, Nadeem ^b   Halka, Anastassi ^a,b   Kielty, Cay M ^a   Walker, Michael G ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Angiogenesis; Hypertension; Restenosis; Transforming growth factor; Vasculature

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; AORTA ANEURYSM; AORTA DISSECTION; ARTERY INJURY; ATHEROGENESIS; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HYPERTENSION; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; MONOCULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RENDU OSLER WEBER DISEASE; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

EID: 13844253337     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2004.11.005     Document Type: Article

References (90)

1. JE De Larco, and GJ Todaro Growth factors from murine sarcoma virus-transformed cells Proc Natl Acad Sci U S A 75 8 1978 4001 4005
2. AB Roberts, LC Lamb, DL Newton, MB Sporn, JE De Larco, and GJ Todaro Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction Proc Natl Acad Sci U S A 77 6 1980 3494 3498
3. B Pasche Role of transforming growth factor beta in cancer J Cell Physiol 186 2 2001 153 168
4. GC Blobe, WP Schiemann, and HF Lodish Role of transforming growth factor beta in human disease N Engl J Med 342 18 2000 1350 1358
5. T Mizuguchi, G Collod-Beroud, T Akiyama, M Abifadel, N Harada, T Morisaki, D Allard, M Varret, M Claustres, H Morisaki, M Ihara, A Kinoshita, KI Yoshiura, C Junien, T Kajii, G Jondeau, T Ohta, T Kishino, Y Furukawa, Y Nakamura, N Niikawa, C Boileau, and N Matsumoto Heterozygous TGFBR2 mutations in Marfan syndrome Nat Genet 36 2004 855 860
6. J Massague, L Attisano, and JL Wrana The TGF-beta family and its composite receptors Trends Cell Biol 4 5 1994 172 178
7. J Saharinen, M Hyytiainen, J Taipale, and J Keski-Oja Latent transforming growth factor-beta binding proteins (LTBPs)-structural extracellular matrix proteins for targeting TGF-beta action Cytokine Growth Factor Rev 10 2 1999 99 117
8. S Sinha, C Nevett, CA Shuttleworth, and CM Kielty Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins Matrix Biol 17 8-9 1998 529 545
9. JS Munger, X Huang, H Kawakatsu, MJ Griffiths, SL Dalton, J Wu, JF Pittet, N Kaminski, C Garat, MA Matthay, DB Rifkin, and D Sheppard The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis Cell 96 3 1999 319 328
10. JP Annes, Y Chen, JS Munger, and DB Rifkin Integrin {alpha}V{beta}6- mediated activation of latent TGF-{beta} requires the latent TGF-{beta} binding protein-1 J Cell Biol 165 5 2004 723 734
11. L Attisano, JL Wrana, F Lopez-Casillas, and J Massague TGF-beta receptors and actions Biochim Biophys Acta 1222 1 1994 71 80
12. JL Wrana, L Attisano, R Wieser, F Ventura, and J Massague Mechanism of activation of the TGF-beta receptor Nature 370 6488 1994 341 347
13. H Ikedo, K Tamaki, S Ueda, S Kato, M Fujii, P ten Dijke, and S Okuda Smad protein and TGF-beta signaling in vascular smooth muscle cells Int J Mol Med 11 5 2003 645 650
14. MJ Goumans, and C Mummery Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice Int J Dev Biol 44 3 2000 253 265
15. E Piek, CH Heldin, and P ten Dijke Specificity, diversity, and regulation in TGF-beta superfamily signaling FASEB J 13 15 1999 2105 2124
16. A Zwijsen, MA van Rooijen, MJ Goumans, N Dewulf, EA Bosman, P ten Dijke, CL Mummery, and D Huylebroeck Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis Dev Dyn 218 4 2000 663 670
17. RL Heimark, DR Twardzik, and SM Schwartz Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets Science 233 4768 1986 1078 1080
18. MJ Pollman, L Naumovski, and GH Gibbons Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells Circulation 99 15 1999 2019 2026
19. G Muller, J Behrens, U Nussbaumer, P Bohlen, and W Birchmeier Inhibitory action of transforming growth factor beta on endothelial cells Proc Natl Acad Sci U S A 84 16 1987 5600 5604
20. MS Pepper, JD Vassalli, L Orci, and R Montesano Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis Exp Cell Res 204 2 1993 356 363
21. RA Majack Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures J Cell Biol 105 1 1987 465 471
22. EJ Battegay, EW Raines, RA Seifert, DF Bowen-Pope, and R Ross TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop Cell 63 3 1990 515 524
23. D Murray, A Russell, J Ghosh, MG Walker, and CM Kielty Adenoviral mediated delivery of TGFB-1 into HCASMC promotes a developing vascular extracellular matrix Tissue Eng 9 4 2003 837 [Abstract]
24. F Verrecchia, and A Mauviel Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation J Invest Dermatol 118 2 2002 211 215
25. TA McCaffrey, S Consigli, B Du, DJ Falcone, TA Sanborn, AM Spokojny, and HL Bush Jr Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1 J Clin Invest 96 6 1995 2667 2675
26. S Topouzis, and MW Majesky Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta Dev Biol 178 2 1996 430 445
27. MC Dickson, JS Martin, FM Cousins, AB Kulkarni, S Karlsson, and RJ Akhurst Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice Development 121 6 1995 1845 1854
28. M Oshima, H Oshima, and MM Taketo TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis Dev Biol 179 1 1996 297 302
29. MJ Goumans, A Zwijsen, MA van Rooijen, D Huylebroeck, BA Roelen, and CL Mummery Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice Development 126 16 1999 3473 3483
30. HAJ Struijker, S Boudier, FRM Stasson, and AC le Nobel Ferdinand Angiogenesis B Levy A Tedgui Biology of the arterial wall 1999 Kluwer Academic Press Boston 115 128
31. MS Pepper Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev 8 1 1997 21 43
32. SJ Mandriota, PA Menoud, and MS Pepper Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells J Biol Chem 271 19 1996 11500 11505
33. N Ueki, M Nakazato, T Ohkawa, T Ikeda, Y Amuro, and T Hada Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth Biochim Biophys Acta 1137 2 1992 189 196
34. N Ueki, T Ohkawa, Y Yokoyama, J Maeda, Y Kawai, and T Ikeda Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection Jpn J Cancer Res 84 6 1993 589 593
35. S Koochekpour, A Merzak, and GJ Pilkington Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro Cancer Lett 102 1-2 1996 209 215
36. GJ Dolecki, and DT Connolly Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells Biochem Biophys Res Commun 180 2 1991 572 578
37. L Pertovaara, A Kaipainen, T Mustonen, A Orpana, N Ferrara, and O Saksela Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells J Biol Chem 269 9 1994 6271 6274
38. KA McAllister, KM Grogg, DW Johnson, CJ Gallione, MA Baldwin, and CE Jackson Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat Genet 8 4 1994 345 351
39. DW Johnson, JN Berg, MA Baldwin, CJ Gallione, I Marondel, and SJ Yoon Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 Nat Genet 13 2 1996 189 195
40. DS van den, CL Mummery, and CJ Westermann Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis Cardiovasc Res 58 1 2003 20 31
41. L Pereira, K Andrikopoulos, J Tian, SY Lee, DR Keene, R Ono, DP Reinhardt, LY Sakai, NJ Biery, T Bunton, HC Dietz, and F Ramirez Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome Nat Genet 17 2 1997 218 222
42. ER Neptune, PA Frischmeyer, DE Arking, L Myers, TE Bunton, B Gayraud, F Ramirez, LY Sakai, and HC Dietz Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 3 2003 407 411
43. LV Goodman, and RA Majack Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture J Biol Chem 264 9 1989 5241 5244
44. MM Shull, I Ormsby, AB Kier, S Pawlowski, RJ Diebold, M Yin, R Allen, C Sidman, G Proetzel, and D Calvin Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 6397 1992 693 699
45. AB Kulkarni, CG Huh, D Becker, A Geiser, M Lyght, KC Flanders, AB Roberts, MB Sporn, JM Ward, and S Karlsson Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death Proc Natl Acad Sci U S A 90 2 1993 770 774
46. S Tsunawaki, M Sporn, A Ding, and C Nathan Deactivation of macrophages by transforming growth factor-beta Nature 334 6179 1988 260 262
47. J Lomo, HK Blomhoff, K Beiske, T Stokke, and EB Smeland TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes J Immunol 154 4 1995 1634 1643
48. R Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 2 1999 115 126
49. DJ Grainger Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis Arterioscler Thromb Vasc Biol 24 3 2004 399 404
50. E Lutgens, M Gijbels, M Smook, P Heeringa, P Gotwals, VE Koteliansky, and MJ Daemen Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression Arterioscler Thromb Vasc Biol 22 6 2002 975 982
51. DJ Grainger, CM Witchell, and JC Metcalfe Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta Nat Med 1 10 1995 1067 1073
52. DJ Grainger, and JC Metcalfe Tamoxifen: teaching an old drug new tricks? Nat Med 2 4 1996 381 385
53. TA McCaffrey, B Du, C Fu, PJ Bray, TA Sanborn, E Deutsch, N Tarazona, A Shaknovitch, G Newman, C Patterson, and HL Bush Jr The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance J Mol Cell Cardiol 31 9 1999 1627 1642
54. TA McCaffrey, B Du, S Consigli, P Szabo, PJ Bray, L Hartner, BB Weksler, TA Sanbom, G Bergman, and HL Bush Jr Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells J Clin Invest 100 9 1997 2182 2188
55. S Kojima, PC Harpel, and DB Rifkin Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration J Cell Biol 113 6 1991 1439 1445
56. V Martin-Paredero, J Vadillo, J Diaz, A Espinosa, C Berga, J Segura, J Sanchez, A Barbod, C Villaverde, and CM Richard Fibrinogen and fibrinolysis in blood and in the arterial wall: its role in advanced atherosclerotic disease Cardiovasc Surg 6 5 1998 457 462
57. M Yokota, S Ichihara, TL Lin, N Nakashima, and Y Yamada Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 24 2000 2783 2787
58. P Borkowski, MJ Robinson, JW Kusiak, A Borkowski, C Brathwaite, and WJ Mergner Studies on TGF-beta 1 gene expression in the intima of the human aorta in regions with high and low probability of developing atherosclerotic lesions Mod Pathol 8 5 1995 478 482
59. A Cucina, P Sapienza, V Corvino, V Borrelli, V Mariani, B Randone, DL Santoro, and A Cavallaro Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta 1 Surgery 127 3 2000 316 322
60. F Cambien, S Ricard, A Troesch, C Mallet, L Generenaz, A Evans, D Arveiler, G Luc, JB Ruidavets, and O Poirier Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study Hypertension 28 5 1996 881 887
61. E Porreca, C Di Febbo, E Vitacolonna, G Baccante, A Di Castelnuovo, A Angelini, F Febo, M Di Nisio, and F Cuccurullo Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin Am J Hypertens 15 9 2002 759 765
62. S Cottone, G Mule, F Amato, R Riccobene, A Vadala, MC Lorito, F Raspanti, and G Cerasola Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure J Nephrol 15 6 2002 643 648
63. M Suthanthiran, B Li, JO Song, R Ding, VK Sharma, JE Schwartz, and P August Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage Proc Natl Acad Sci U S A 97 7 2000 3479 3484
64. U Derhaschnig, M Shehata, H Herkner, A Bur, C Woisetschlager, AN Laggner, and MM Hirschl Increased levels of transforming growth factor-beta1 in essential hypertension Am J Hypertens 15 3 2002 207 211
65. A Hennessy, S Orange, N Willis, DM Painter, A Child, and JS Horvath Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia Clin Exp Pharmacol Physiol 29 11 2002 968 971
66. F Lyall, H Simpson, JN Bulmer, A Barber, and SC Robson Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction Am J Pathol 159 5 2001 1827 1838
67. H Kurihara, M Yoshizumi, T Sugiyama, F Takaku, M Yanagisawa, T Masaki, M Hamaoki, H Kato, and Y Yazaki Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells Biochem Biophys Res Commun 159 3 1989 1435 1440
68. DJ Stewart, RD Levy, P Cernacek, and D Langleben Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114 6 1991 464 469
69. WA Border, and NA Noble Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis Hypertension 31 1 Pt. 2 1998 181 188
70. EG Nabel, L Shum, VJ Pompili, ZY Yang, H San, HB Shu, S Liptay, L Gold, D Gordon, and R Derynck Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia Proc Natl Acad Sci U S A 90 22 1993 10759 10763
71. A Agrotis, J Saltis, and A Bobik Transforming growth factor-beta 1 gene activation and growth of smooth muscle from hypertensive rats Hypertension 23 5 1994 593 599
72. C Laviades, N Varo, and J Diez Transforming growth factor beta in hypertensives with cardiorenal damage Hypertension 36 4 2000 517 522
73. K Sharma, BO Eltayeb, TA McGowan, SR Dunn, B Alzahabi, R Rohde, FN Ziyadeh, and EJ Lewis Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients Am J Kidney Dis 34 5 1999 818 823
74. EL Owens, and AW Clowes Pathobiology of Hyperplastic Intimal Responses P Zilla HP Greisler Tissue engineering of vascular prosthetic grafts 1999 R G Landes 229 240
75. BC Berk Vascular smooth muscle growth: autocrine growth mechanisms Physiol Rev 81 3 2001 999 1030
76. H Itoh, M Mukoyama, RE Pratt, GH Gibbons, and VJ Dzau Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II J Clin Invest 91 5 1993 2268 2274
77. AW Hahn, TJ Resink, T Scott-Burden, J Powell, Y Dohi, and FR Buhler Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function Cell Regul 1 9 1990 649 659
78. SM Dluz, S Higashiyama, D Damm, JA Abraham, and M Klagsbrun Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen J Biol Chem 268 24 1993 18330 18334
79. Y Kayanoki, S Higashiyama, K Suzuki, M Asahi, S Kawata, and Y Matsuzawa The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells Biochem Biophys Res Commun 259 1 1999 50 55
80. MW Majesky, V Lindner, DR Twardzik, SM Schwartz, and MA Reidy Production of transforming growth factor beta 1 during repair of arterial injury J Clin Invest 88 3 1991 904 910
81. J Chamberlain, J Gunn, SE Francis, CM Holt, ND Arnold, and DC Cumberland TGFbeta is active, and correlates with activators of TGFbeta, following porcine coronary angioplasty Cardiovasc Res 50 1 2001 125 136
82. S Sinha, AM Heagerty, CA Shuttleworth, and CM Kielty Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury Cardiovasc Res 53 4 2002 971 983
83. J Fingerle, R Johnson, AW Clowes, MW Majesky, and MA Reidy Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery Proc Natl Acad Sci U S A 86 21 1989 8412 8416
84. M Shah, DM Foreman, and MW Ferguson Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents J Cell Sci 107 Pt. 5 1994 1137 1157
85. M Shah, DM Foreman, and MW Ferguson Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring J Cell Sci 108 Pt 3 1995 985 1002
86. S O'Kane, and MW Ferguson Transforming growth factor beta s and wound healing Int J Biochem Cell Biol 29 1 1997 63 78
87. MW Ferguson, and S O'Kane Scar-free healing: from embryonic mechanisms to adult therapeutic intervention Philos Trans R Soc Lond B Biol Sci 359 1145 2004 (May 29) 839 850
88. JD Smith, SR Bryant, LL Couper, CP Vary, PJ Gotwals, VE Koteliansky, and V Lindner Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth Circ Res 84 10 1999 1212 1222
89. PA Kingston, S Sinha, A David, MG Castro, PR Lowenstein, and AM Heagerty Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition Circulation 104 21 2001 2595 2601
90. PA Kingston, S Sinha, CE Appleby, A David, T Verakis, MG Castro, PR Lowenstein, and AM Heagerty Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty Circulation 108 22 2003 2819 2825